Last updated: March 13, 2026
Sponsor: Oslo University Hospital
Overall Status: Completed
Phase
N/A
Condition
Mental Disability
Memory Loss
Mild Cognitive Impairment
Treatment
Bilateral Bispectral Index and EEG
Clinical Study ID
NCT04529304
2019/32173
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
.
Participants are eligible to be included in the study only if all of the following criteria apply:
Age
- Participant must be above the age of 18 years , at the time of signing the informed consent.
Sex
- Male and/or female
Informed Consent
- Capable of giving signed informed consent as described in protocol which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the protocol
Exclusion Criteria
Participants are excluded from the study if any of the following criteria apply:
Psychiatric disorders
Pregnancy
Breast feeding
Using antiepileptic drugs.
Central neurological disease
Unable to complete baseline CANTAB-test.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Bilateral Bispectral Index and EEG
Phase:
Study Start date:
January 08, 2021
Estimated Completion Date:
March 13, 2026
Study Description
Connect with a study center
Oslo University Hospital
Oslo, Oslo County 0124
NorwaySite Not Available
Oslo University Hospital
Oslo 3143244, 0124
NorwaySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.